Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02327 MEILLEUREHEALTH
RTNominal up0.135 +0.006 (+4.651%)
Others

30/12/2020 15:46

Meilleure Health (02327) to buy 3% of company at RMB18m

[ET Net News Agency, 30 December 2020] Meilleure Health International Industry Group
Limited (02327) said the company (through its wholly owned subsidiary, namely Meilleure
Health Technology) has entered into an investment agreement with Shenzhen Mason Vap and
its existing shareholders and de facto controllers to subscribe for a 2% equity interest
and acquire a 1% equity interest in Shenzhen Mason Vap.
Pursuant to the agreement, Meilleure Health Technology will subscribe for a 2% equity
interest in Shenzhen Mason Vap at a consideration of RMB12 million by way of additional
issue with a capital contribution. In addition, upon completion of the capital increase,
Meilleure Health Technology will acquire a 1% equity interest in Shenzhen Mason Vap from
one of the existing shareholders of Shenzhen Mason Vap at the price of RMB6 million.
Shenzhen Mason Vap is a company engaged in the research, development and manufacture of
nicotine-containing atomisation products on a global scale. (RC)

Remark: Real time quote last updated: 24/04/2024 15:09
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.